PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury

被引：0
|
作者：
Flora M. Hammond
David N. Alexander
Andrew J. Cutler
Stephen D’Amico
Rachelle S. Doody
William Sauve
Richard D. Zorowitz
Charles S. Davis
Paul Shin
Fred Ledon
Charles Yonan
Andrea E. Formella
Joao Siffert
机构：
[1] Indiana University School of Medicine,Physical Medicine and Rehabilitation
[2] Rehabilitation Hospital of Indiana,undefined
[3] University of California,undefined
[4] Florida Clinical Research Center,undefined
[5] LLC,undefined
[6] Cornerstone Medical Group,undefined
[7] Baylor College of Medicine,undefined
[8] TMS NeuroHealth Centers,undefined
[9] MedStar National Rehabilitation Network,undefined
[10] CSD Biostatistics,undefined
[11] Inc.,undefined
[12] Avanir Pharmaceuticals,undefined
[13] Inc.,undefined
来源：
BMC Neurology | / 16卷
关键词：
Dextromethorphan; Quinidine; Pseudobulbar affect; Dementia; Brain injuries; Stroke; Neuropsychiatric symptoms; Center for neurologic study-lability scale;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Phase II, open-label study of dabrafenib plus trametinib in patients with BRAF mutation-positive melanoma brain metastases: A GSK-sponsored trial
    Davies, Michael A.
    Martins, Karla D.
    Sessa, Tracey
    Swann, Suzanne
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [42] Patupilone for the treatment of recurrent/progressive brain metastases in patients (pts) with non-small cell lung cancer (NSCLC): An open-label phase II study
    Abrey, L. E.
    Wen, P.
    Govindan, R.
    Reimers, H.
    Rigas, J. R.
    Robins, H. I.
    Allen-Freda, E.
    Gao, B.
    Ko, J.
    Johri, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] Efficacy and Safety of Apatinib for Radiation- induced Brain Injury Among Patients With Head and Neck Cancer: An Open-Label, Single-Arm, Phase 2 Study
    He, Lei
    Pi, Yaxuan
    Li, Yi
    Wu, Ying
    Jiang, Jingru
    Rong, Xiaoming
    Cai, Jinhua
    Yue, Zongwei
    Cheng, Jinping
    Li, Honghong
    Chua, Melvin Lee Kiang
    Simone, Charles B.
    Aronow, Wilbert S.
    Lattanzi, Simona
    Palmer, Joshua D.
    Gaertner, Jan
    Glass, Jon
    Chen, Pingyan
    Tang, Yamei
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 113 (04): : 796 - 804
  • [44] Treatment of recurrent or progressive brain metastases with patupilone in patients with non-small cell lung cancer (NSCLC): results of a multicenter, open-label phase II study
    Abrey, L.
    Johri, A.
    Wen, P. Y.
    Govindan, R.
    Reimers, H. J.
    Robins, H. I.
    de Bedout, S.
    Hennan, L.
    Ko, J. L.
    Rigas, J. R.
    EJC SUPPLEMENTS, 2007, 5 (04): : 372 - 372
  • [45] A PROSPECTIVE PHASE II, OPEN-LABEL, SINGLE-ARM, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF SEG101 (CRIZANLIZUMAB) IN SICKLE CELL DISEASE PATIENTS WITH PRIAPISM (SPARTAN)
    Burnett, A.
    El Rassi, F.
    Darbari, D.
    Paulose, J.
    Laine, D.
    Purkayastha, D.
    Kato, G.
    JOURNAL OF SEXUAL MEDICINE, 2020, 17 (01): : S43 - S43
  • [46] A Prospective Phase II, Open-Label, Single-Arm, Multicenter Study to Assess the Efficacy and Safety of SEG101 (Crizanlizumab) in Sickle Cell Disease Patients with Priapism (SPARTAN)
    El Rassi, Fuad A.
    Darbari, Deepika S.
    Burnett, Arthur
    Paulose, Jincy
    Laine, Dramane I.
    Purkayastha, Das
    Kato, Gregory J.
    BLOOD, 2019, 134
  • [47] Activity of patupilone for the treatment of recurrent or progressive brain metastases in patients (pts) with non-small cell lung cancer (NSCLC): An open-label, multicenter, phase II study
    Abrey, L.
    Wen, P. Y.
    Govindan, R.
    Reimers, H. J.
    Rigas, J. R.
    Robins, H. I.
    de Bedout, S.
    O'Connell, C.
    Li, X.
    Johri, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [48] A phase II, open-label, multi-center study of ANG1005, a novel brain penetrant taxane derivative, in breast cancer patients with recurrent CNS metastases
    Tang, S-C
    Bates, S.
    Kesari, S.
    Brenner, A. J.
    Anders, C. K.
    Garcia, A.
    Ibrahim, N. K.
    Tkaczuk, K. H. R.
    Kumthekar, P.
    CANCER RESEARCH, 2016, 76
  • [49] An open-label, multicenter, phase Ib/II study of rebastinib in combination with paclitaxel in a dose-expansion cohort to assess safety and preliminary efficacy in patients with advanced or metastatic endometrial cancer.
    Janku, Filip
    Hamilton, Erika Paige
    Chu, Christina
    Richardson, Debra L.
    Arend, Rebecca Christian
    Kuida, Keisuke
    Achour, Haroun
    Ruiz-Soto, Rodrigo
    Hays, John L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [50] TARGET TRIAL: A PHASE I/II OPEN-LABEL MULTICENTER STUDY TO ASSESS SAFETY, TOLERABILITY, AND CLINICAL EFFICACY OF AZD4547 IN PATIENTS WITH RELAPSED/REFRACTORY FGFR FUSION POSITIVE GLIOMA
    Picca, Alberto
    Di Stefano, Anna Luisa
    Savatovsky, Julien
    Ducray, Francois
    Chinot, Olivier
    Moyal, Elisabeth Cohen-Jonathan
    Augereau, Paule
    Schmitt, Yohann
    Lerond, Julie
    Rousseaux, Nabila
    Fardeau, Christine
    Mokhtari, Karima
    Bielle, Franck
    Meyronet, David
    Iavarone, Antonio
    Sanson, Marc
    NEURO-ONCOLOGY, 2023, 25
12345